Israel Englander Emergent Bio Solutions Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Millennium Management LLC holds 77,824 shares of EBS stock, worth $786,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,824

Previous 755,432 89.7%

Holding current value

$786,800

Previous $4.82 Million 85.76%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$5.63 - $9.32 $3.81 Million - $6.32 Million	-677,608 Reduced 89.7%	77,824 $686,000
Q2 2025 Aug 14, 2025	SELL	$4.26 - $6.94 $7.44 Million - $12.1 Million	-1,747,056 Reduced 69.81%	755,432 $4.82 Million
Q1 2025 May 15, 2025	BUY	$4.66 - $11.66 $4.76 Million - $11.9 Million	1,020,582 Added 68.87%	2,502,488 $12.2 Million
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $5.19 Million - $8.04 Million	671,947 Added 82.96%	1,481,906 $14.2 Million
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $779,881 - $2.01 Million	-136,343 Reduced 14.41%	809,959 $6.76 Million

Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $96,987 - $363,965	52,144 Added 5.83%	946,302 $6.45 Million
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $1.8 Million - $4.1 Million	-1,201,504 Reduced 57.33%	894,158 $2.26 Million
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $1.48 Million - $2.57 Million	813,388 Added 63.43%	2,095,662 $5.03 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $6.44 Million - $11.6 Million	876,273 Added 215.83%	1,282,274 $9.42 Million
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $3.16 Million - $6.61 Million	406,001 New	406,001 $4.21 Million
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $6.96 Million - $12.4 Million	-346,449 Reduced 83.13%	70,326 $1.48 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $2.08 Million - $3.31 Million	-75,861 Reduced 15.4%	416,775 $12.9 Million
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $3.37 Million - $4.82 Million	92,268 Added 23.05%	492,636 $20.2 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $13 Million - $21.6 Million	392,709 Added 5127.42%	400,368 $17.4 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $40,756 - $53,764	814 Added 11.89%	7,659 $383,000
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $112,484 - $159,874	1,987 Added 40.9%	6,845 $431,000
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $3.8 Million - $5.52 Million	-44,116 Reduced 90.08%	4,858 $451,000
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $6.59 Million - $9.28 Million	-83,295 Reduced 62.97%	48,974 $4.39 Million
Q3 2020 Nov 16, 2020	BUY	$81.91 - $134.94 $10.4 Million - $17.2 Million	127,333 Added 2579.68%	132,269 $13.7 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $268,172 - $441,870	4,936 New	4,936 $390,000
Q1 2020 May 14, 2020	SELL	$49.34 - $68.76 $1.1 Million - $1.53 Million	-22,261 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $18 Million - $20.8 Million	-352,248 Reduced 94.06%	22,261 $1.2 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $15.2 Million - $21.4 Million	374,509 New	374,509 $19.6 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $29.9 Million - $38.2 Million	-575,009 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $16.5 Million - $19 Million	-342,056 Reduced 37.3%	575,009 $29 Million
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $9.31 Million - $11.4 Million	209,581 Added 29.62%	917,065 $48.3 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $2.43 Million - $3.07 Million	64,321 Added 10.0%	707,484 $32.9 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $22 Million - $26 Million	643,163	643,163 $26 Million

Others Institutions Holding EBS

# of Institutions

192

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account